CA Stock MarketDetailed Quotes
WAVE Waverley Pharma Inc
- 0.015
- 0.0000.00%
15min DelayPost Market Jul 2 16:00 ET
810.00KMarket Cap-1500P/E (TTM)
0.000High0.000Low1.01KVolume0.030Open0.015Pre Close16.59Turnover0.03552wk High0.01%Turnover Ratio54.00MShares0.01552wk Low-0.01EPS TTM203.27KFloat Cap0.600Historical HighLossP/E (Static)13.55MShs Float0.015Historical Low-0.04EPS LYR0.00%Amplitude--Dividend TTM-0.58P/B1Lot Size--Div YieldTTM
Waverley Pharma Inc Key Stats
Quarterly+Annual
YOY
| (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | -66.95%412.09K | -72.82%48.73K | -71.90%96.09K | -64.77%148.59K | -60.95%118.69K | -28.87%1.25M | -61.60%179.24K | -10.66%341.93K | -22.38%421.76K |
| Operating revenue | --0 | -66.95%412.09K | -72.82%48.73K | -71.90%96.09K | -64.77%148.59K | -60.95%118.69K | -28.87%1.25M | -61.60%179.24K | -10.66%341.93K | -22.38%421.76K |
| Cost of revenue | 0 | -65.50%332.29K | -33.38%97.54K | -66.56%71.44K | -86.93%46.43K | -52.80%116.87K | -37.06%963.04K | -67.75%146.43K | -34.53%213.62K | -21.64%355.38K |
| Gross profit | 0 | -71.88%79.8K | -248.76%-48.82K | -80.79%24.64K | 53.92%102.16K | -96.77%1.82K | 27.45%283.79K | 156.68%32.82K | 127.38%128.31K | -26.13%66.37K |
| Operating expense | -31.02%225.67K | 42.49%1.31M | 23.47%352.44K | 65.30%305.99K | 46.81%328.09K | 43.55%327.17K | -8.67%921.95K | -5.08%285.44K | -14.20%185.11K | -9.46%223.48K |
| Selling and administrative expenses | -41.09%160.83K | -0.90%1.13M | 17.65%337.51K | -40.77%245.85K | 25.81%271.69K | 28.85%273.01K | 15.69%1.14M | -4.86%286.87K | 95.95%415.11K | -9.92%215.95K |
| Research and development costs | 19.71%64.84K | 187.28%234.58K | 3.20%63.88K | 1,189.58%60.13K | 649.12%56.4K | 237.83%54.17K | 218.68%81.66K | 7,837.38%61.9K | 19.69%4.66K | 6.19%7.53K |
| Other taxes | ---- | 83.57%-48.95K | ---- | ---- | ---- | ---- | ---297.99K | ---63.33K | ---234.66K | ---- |
| Operating profit | 30.64%-225.67K | -93.35%-1.23M | -58.84%-401.25K | -395.27%-281.34K | -43.81%-225.93K | -89.58%-325.36K | 18.89%-638.16K | 12.26%-252.62K | 64.34%-56.81K | -0.08%-157.11K |
| Net non-operating interest income (expenses) | -176.87%-32.44K | -360.71%-76.65K | -195.52%-29.12K | -415.82%-20.45K | -1,135.85%-15.37K | -642.52%-11.72K | -447.84%-16.64K | -257.60%-9.85K | -741.61%-3.96K | -365.92%-1.24K |
| Non-operating interest expense | 176.87%32.44K | ---- | ---- | 415.82%20.45K | ---- | --11.72K | ---- | ---- | --3.96K | ---- |
| Total other finance cost | ---- | 360.71%76.65K | ---- | ---- | 1,135.85%15.37K | ---- | 447.84%16.64K | ---- | ---- | 365.92%1.24K |
| Other net income (expenses) | -142.13%-6.02K | -9,741.75%-913.51K | -1,738.02%-903.2K | 86.59%-8.17K | -99.74%347 | 98.20%-2.49K | -39.70%-9.28K | 143.55%55.14K | -948.01%-60.94K | 1,258.18%134.31K |
| Gain on sale of security | -142.13%-6.02K | 93.77%-578 | -82.36%9.73K | 86.59%-8.17K | -99.74%347 | 98.20%-2.49K | 80.91%-9.28K | 385.15%55.14K | -948.01%-60.94K | 1,258.18%134.31K |
| Special income (charges) | ---- | ---942.62K | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| -Less:Impairment of capital assets | ---- | --942.62K | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Other non-operating income (expenses) | ---- | --29.69K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Income before tax | 22.21%-264.13K | -234.91%-2.22M | -543.21%-1.33M | -154.67%-309.96K | -902.23%-240.96K | -9.19%-339.56K | 16.63%-664.08K | 22.65%-207.33K | 26.50%-121.71K | 83.68%-24.04K |
| Income tax | ||||||||||
| Earnings from equity interest net of tax | ||||||||||
| Net income | 22.21%-264.13K | -234.91%-2.22M | -543.21%-1.33M | -154.67%-309.96K | -902.23%-240.96K | -9.19%-339.56K | 16.63%-664.08K | 22.65%-207.33K | 26.50%-121.71K | 83.68%-24.04K |
| Net income continuous operations | 22.21%-264.13K | -234.91%-2.22M | -543.21%-1.33M | -154.67%-309.96K | -902.23%-240.96K | -9.19%-339.56K | 16.63%-664.08K | 22.65%-207.33K | 26.50%-121.71K | 83.68%-24.04K |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | 22.21%-264.13K | -234.91%-2.22M | -543.21%-1.33M | -154.67%-309.96K | -902.23%-240.96K | -9.19%-339.56K | 16.63%-664.08K | 22.65%-207.33K | 41.27%-121.71K | 83.68%-24.04K |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | 22.21%-264.13K | -234.91%-2.22M | -543.21%-1.33M | -154.67%-309.96K | -902.23%-240.96K | -9.19%-339.56K | 16.63%-664.08K | 22.65%-207.33K | 41.27%-121.71K | 83.68%-24.04K |
| Diluted earnings per share | 51.09%-0.0049 | -300.00%-0.04 | -0.02 | -343.66%-0.01 | -902.70%-0.0045 | 0.00%-0.01 | 0.00%-0.01 | 0 | 41.27%-0.0023 | 83.69%-0.0004 |
| Basic earnings per share | 51.09%-0.0049 | -300.00%-0.04 | -0.02 | -343.66%-0.01 | -902.70%-0.0045 | 0.00%-0.01 | 0.00%-0.01 | 0 | 41.27%-0.0023 | 83.69%-0.0004 |
| Dividend per share | ||||||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CA
Overall
Symbol
Latest Price
%Chg